Tertiary Lymphoid Structures as Predictors of Recurrence in Colorectal Cancer: Development and Validation of a
Xian-Hua Lei1, Rong Li1, Dong-Mei Wang1
1Department of Pathology, Ganzhou Cancer Hospital, The Affiliated Cancer Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Cancer Medicine
|August 1, 2026
Summary
A machine-learning model using location-specific tertiary lymphoid structures (TLS) shows moderate success in predicting colorectal cancer (CRC) recurrence. This approach may aid in postoperative risk stratification for stage II-III CRC patients.
Area of Science:
- Oncology
- Immunology
- Computational Biology
Background:
- Tertiary lymphoid structures (TLS) are immune aggregates in the tumor microenvironment with prognostic value.
- The predictive significance of location-specific TLS features for colorectal cancer (CRC) recurrence is not well-established.
- This study aimed to develop and validate a machine-learning (ML) model integrating TLS features for CRC recurrence prediction.
Purpose of the Study:
- To develop and internally validate a machine-learning (ML) model for predicting recurrence in stage II-III colorectal cancer (CRC).
- To assess the value of location-specific tertiary lymphoid structures (TLS) features in predicting CRC recurrence.
Main Methods:
- Retrospective analysis of 224 stage II-III CRC patients, split into training (n=156) and validation (n=68) cohorts.
- Semi-quantitative scoring of intratumoral, invasive-front, and peritumoral TLS by pathologists.
- Machine-learning model development using LASSO selection, five algorithms, stratified cross-validation, and SHAP interpretation.
Main Results:
- The ML model, incorporating peritumoral TLS score, invasive-front TLS score, and CEA, achieved an AUC of 0.718 in internal validation.
- Invasive-front TLS score was identified as the most influential predictor by SHAP analysis.
- The model effectively stratified patients into high- and low-risk groups with significantly different disease-free survival (log-rank p < 0.0001).
Conclusions:
- A TLS-based ML model demonstrated moderate internal validation performance for predicting CRC recurrence.
- Location-specific TLS features show potential for postoperative risk stratification in CRC patients.
- External, multicenter, and molecularly integrated validation is necessary prior to clinical implementation.
